| Financial Year |
March 31 2023 |
| Monetary Funds |
7,024,361,658.90 |
| Held-for-trading Financial Assets |
130,011,495.03 |
| Notes Receivable |
28,187,187.99 |
| Accounts Receivable |
4,719,412,479.83 |
| Advances to Suppliers |
1,275,620,719.05 |
| Other Receivables |
428,543,666.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,761,568,937.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
100,000,000.00 |
| Other Current Assets |
200,637,909.94 |
| Total Current Assets |
18,040,007,763.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
260,558,333.50 |
| Long-term Equity Investment |
249,635,383.18 |
| Investment Properties |
129,197,879.62 |
| Fixed Assetes |
1,193,705,461.83 |
| Under-construction Projects |
47,565,271.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
500,321,600.43 |
| R&D expenses |
30,312,514.50 |
| Goodwill |
232,300,050.08 |
| Long-Term Deferred and Prepaid Expenses |
9,524,492.52 |
| Deferred Income Tax Assets |
316,606,401.77 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,208,913,095.95 |
| Total Assets |
22,248,920,859.48 |
| Short-Term Loans |
436,911,060.51 |
| Trading Financial liabilities |
40,982,102.26 |
| Notes Payable |
36,404,895.19 |
| Accounts Payable |
4,720,178,586.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
161,081,580.17 |
| Taxes Payable |
91,761,917.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
469,371,091.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
117,018,285.13 |
| Other Current Liabilities |
177,922,973.82 |
| Sub-Total of Current Liabilities |
10,119,118,773.01 |
| Long-term Loans |
161,580,174.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,512,987.72 |
| Deferred Income Tax Liabilities |
109,724,999.77 |
| Other Non-Current Liabilities |
12,185,823.95 |
| Sub-Total of Non-Current Liabilities |
949,094,423.64 |
| Total Liabilities |
11,068,213,196.65 |
| Paid-In Capital(Or Share Stock) |
1,237,408,937.00 |
| Capital Surplus |
2,363,948,831.25 |
| Surplus Reserve |
1,177,797,968.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,573,282,821.18 |
| Minority Stockholder's Interest |
130,402,480.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,050,305,181.89 |
| Owner's Equity（Stockholder's Equity） |
11,180,707,662.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,248,920,859.48 |
